Literature DB >> 11410197

Variation in antibiotic use in the European Union.

O Cars, S Mölstad, A Melander.   

Abstract

Data on antibiotic use are not publicly available in most European Union countries. We obtained data for non-hospital antibiotic sales for 1997 from the 15 member states and analysed these according to the Anatomic Therapeutic Chemical classification system, and expressed them as defined daily doses per 1000 people per day. Sales of antibiotics varied more than four-fold: France (36.5), Spain (32.4), Portugal (28.8), and Belgium (26.7) had the highest sales, whereas the Netherlands (8.9), Denmark (11.3), Sweden (13.5), and Germany (13.6) had the lowest. There was also profound variation in use of different classes of antibiotics. Detailed knowledge of antibiotic use is necessary to implement national strategies for optimum antibiotic use, and to address the threat posed by resistant microorganisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410197     DOI: 10.1016/S0140-6736(00)04972-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  129 in total

1.  Impact of drug policy on the use of parenteral cephalosporins in Italy.

Authors:  Gianfranco Damiani; Bruno Federico; Marco Oradei; Rino Bellocco; Gian Carlo Vanini
Journal:  Pharm World Sci       Date:  2002-10

2.  Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.

Authors:  Erwin M Brown; Richard Wise
Journal:  BMJ       Date:  2002-06-08

3.  Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties.

Authors:  Eva Melander; Aase Nissen; Karin Henricson; Juan Merlo; Sigvard Mölstad; Jens P Kampmann; Thor Lithman; Ebba Holme Hansen; Arne Melander
Journal:  Eur J Clin Pharmacol       Date:  2003-07-15       Impact factor: 2.953

Review 4.  Overcoming resistance.

Authors:  Caroline Hadley
Journal:  EMBO Rep       Date:  2004-06       Impact factor: 8.807

Review 5.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

6.  Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates.

Authors:  María-Rosario Baquero; Annika I Nilsson; María del Carmen Turrientes; Dorthe Sandvang; Juan Carlos Galán; Jose Luís Martínez; Niels Frimodt-Møller; Fernando Baquero; Dan I Andersson
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

7.  European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.

Authors:  R H Vander Stichele; M M Elseviers; M Ferech; S Blot; H Goossens
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 8.  [Use of prescription drugs in Spain and Europe].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2011-10-22       Impact factor: 1.137

9.  [Variability in prescribing penicillins in the Segovia (Spain) Health Area].

Authors:  José María Pinilla Sánchez; José María Eiros Bouza; Elena Moreno Sánchez; Saturio Vega Quiroga
Journal:  Aten Primaria       Date:  2012-01-31       Impact factor: 1.137

10.  Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain.

Authors:  Lars Bjerrum; Albert Boada; Josep M Cots; Carlos Llor; Dolors Forés Garcia; Bente Gahrn-Hansen; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.